Clinical Trial Record

Return to Clinical Trials

Pancreatic Cancer and Diabetes Mellitus


2025-01-03


2026-09-01


2026-09-01


150

Study Overview

Pancreatic Cancer and Diabetes Mellitus

The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are: 1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? 2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition. The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.

Investigators will prospectively collect data from patients with pancreatic cancer after surgery in participant centers.

  • Pancreatic Cancer
  • Surgery
  • Diabetes Mellitus
  • DIAGNOSTIC_TEST: All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.
  • NMU-3CDM-2B

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2024-09-02  

N/A  

2025-06-26  

2024-09-02  

N/A  

2025-07-01  

2024-09-05  

N/A  

2025-06  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
Primary Outcome MeasuresMeasure DescriptionTime Frame
Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)The diagnosis of glucose disorders should be made applying criteria of the American Diabetes Association.From enrollment to five years after the end of the surgery
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Overall SurvivalFrom enrollment to five years after the end of the surgery
Disease-Free SurvivalFrom enrollment to five years after the end of the surgery

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Tuo Li, Doctor

Phone Number: 86-13918507887

Email: dr.lituo@smmu.edu.cn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    1. male or female Chinese subjects; 2. Age ≥ 18 years; 3. patients with pancreatic cancer who are proposed to undergo pancreatectomy by pancreaticobiliary surgery at our hospital; 4. those who voluntarily completed the Pancreatobiliary Surgery Cohort Study and signed the informed consent; 5. those who have completed and banked serum and pathological specimens at our hospital.
    -
    Exclusion Criteria:
    1. those with a previous history of comorbid diabetes mellitus or pre-diabetes mellitus, or preoperative HbA1C ≥ 6.0% or fasting blood glucose ≥ 6.1 mmol/l; 2. those with positive islet-associated antibodies 3. those with the presence of medications, endocrine disease exposures that can lead to a risk of secondary diabetes; 4. pregnant or nursing women; 5. Cognitive impairment or other reasons for failing to sign the informed consent form.
    -

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • STUDY_DIRECTOR: tuo Li, Prof., Shanghai Changzheng Hospital

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available